GSK (GSK) announced that new drug applications have been accepted for review by the China National Medical Products Administration and ...

GSK (GSK) and the University of Oxford announced that they have entered a new research collaboration focused on the potential of cancer ...

Teva Pharmaceutical Industries Ltd. ADR 0.46% $24.53B ...

British pharma giant GSK is heading back to school, pledging up to 50 million pounds sterling (about $62.4 million) to work ...

The Goldsmiths' Company has unveiled a striking new visual identity, updating its rich heritage for a fresh contemporary ...

GSK will invest up to £50 million in the new project, which could inform future development of cancer vaccines.

GSK and the University of Oxford have entered a new research partnership to launch an immuno-prevention programme to explore ...

Copyright © 2025 MarketWatch, Inc. All rights reserved.

Kirkland, Latham, Paul Weiss and others have replaced the likes of Sullivan & Cromwell, Clifford Chance and Slaughter and May ...

GSK's severe asthma therapy Nucala could find a new lease of life as a treatment for chronic obstructive pulmonary disease (COPD) after showing a clear benefit in a phase 3 trial. The headline ...

Over 60% of the targets selected for new GSK drug discovery programmes in 2016 are supported by human genetic evidence. The UK Biobank is funded by the Medical Research Council, Wellcome Trust ...

DelveInsight's 'Tuberculosis Pipeline Insight 2025' report provides comprehensive global coverage of pipeline tuberculosis ...